Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer.
Human immunodeficiency virus (HIV)-infected patients are likely to develop intracranial events. Due to the spread of highly active antiretroviral therapy (HAART), HIV-infected patients now survive longer, and metastatic non-AIDS-defining carcinoma is increasing. A 49-year-old man with HIV infection undergoing treatment with HAART developed an intratumoral hemorrhage in the right frontal lobe. He was diagnosed as having lung adenocarcinoma and was found to have a brain metastasis with bleeding. After treatment for intratumoral bleeding, a contralateral frontal lobe hemorrhage occurred within a month. The patient underwent a second craniotomy and removal of hematoma, followed by whole-brain radiotherapy. He was then treated with four cycles of cisplatin and gemcitabine combination chemotherapy while receiving HAART. A partial response was achieved, though he developed severe hematological toxicities for which the doses of chemotherapy needed to be decreased. However, as a result of treatment, his activities of daily life recovered gradually. This lung cancer patient had been alive for 17 months despite the coexistence of two disorders with a poor prognosis, HIV infection and bleeding brain metastases from lung cancer. This case revealed that physicians must include non-AIDS-defining cancer metastasis to the brain in the differential diagnosis of HIV-infected patients when they show stroke-like symptoms, and such patients may respond to treatment as well as non-HIV-infected patients with advanced lung cancer.
Okuma
Yusuke
Y
Department of Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan.
Hosomi
Yukio
Y
Takagi
Yusuke
Y
Miyamoto
Shingo
S
Shimokawa
Tsuneo
T
Iguchi
Mari
M
Okamura
Tatsuru
T
Saito
Kuniaki
K
Shibuya
Masahiko
M
D000230:Adenocarcinoma / Q000150:complications / Q000556:secondary* / Q000628:therapy; D023241:Antiretroviral Therapy, Highly Active; D001932:Brain Neoplasms / Q000150:complications / Q000556:secondary* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003128:Coma / Q000209:etiology; D016371:Cranial Irradiation; D003399:Craniotomy; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006407:Hematoma, Epidural, Cranial / Q000209:etiology; D006801:Humans; D020300:Intracranial Hemorrhages / Q000209:etiology* / Q000601:surgery; D008175:Lung Neoplasms / Q000150:complications / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant; D012008:Recurrence; D012086:Reoperation; D013997:Time Factors; D016896:Treatment Outcome
Stroke. 2003 Aug;34(8):2060-5
12843354
Chest. 1993 Feb;103(2):410-3
8432128
Rev Pneumol Clin. 2004 Nov;60(5 Pt 3):4S39-4S43
15687993
Curr Opin Oncol. 2008 Sep;20(5):529-33
19106655
J Thorac Oncol. 2007 Apr;2(4):268-72
17409796
Am J Clin Oncol. 1995 Feb;18(1):59-66
7847261
Br J Surg. 1997 Aug;84(8):1068-71
9278642
Folia Neuropathol. 2000;38(4):175-82
11693722
Brain Res. 1998 Jan 19;781(1-2):244-51
9507152
Clin Infect Dis. 2005 Feb 1;40(3):490-1
15668878
Neuroimaging Clin N Am. 2006 Aug;16(3):467-82, viii
16935711
Neurol Med Chir (Tokyo). 2009 Jan;49(1):33-6
19169001
Haemophilia. 2000 Sep;6(5):487-90
11012690
Thorax. 2006 Nov;61(11):1000-8
17071836
AIDS. 2003 Feb 14;17(3):371-5
12556691
Neuroimaging Clin N Am. 1997 Nov;7(4):803-18
9336500
J Thorac Oncol. 2009 Mar;4(3):333-7
19190519
Neurosurgery. 1993 Jan;32(1):124-6
8380630
J Neurosurg Sci. 1985 Jan-Mar;29(1):37-41
4067634
Br J Cancer. 2003 Aug 4;89(3):457-9
12888811